St. Jude Medical, Inc. (STJ) — Financial statements
Income statement, balance sheet, and cash flow for St. Jude Medical, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2016 | 2015 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 5,541↓1.4% | 5,622↑2.2% | 5,501↓0.0% | 5,503↓1.9% | 5,612 | |
| Cost of Revenue | 1,745↑5.6% | 1,653↑5.0% | 1,574↑2.3% | 1,538↑0.4% | 1,532 | |
| Gross Profit | 3,796↓4.4% | 3,969↑1.1% | 3,927↓1.0% | 3,965↓2.8% | 4,079 | |
| Operating Expenses | ||||||
| R&D Expenses | 676↓2.3% | 692↑0.1% | 691↑2.2% | 676↓4.1% | 705 | |
| General & Administrative Expenses | 1,878↑1.2% | 1,856↓1.5% | 1,884↓0.4% | 1,891↓9.3% | 2,085 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 1,878↑1.2% | 1,856↓1.5% | 1,884↓0.4% | 1,891↓9.3% | 2,085 | |
| Other Expenses | 116↑30.3% | 89 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 2,670↑1.3% | 2,637↑2.4% | 2,575↑0.3% | 2,567↓8.0% | 2,790 | |
| Total Costs & Expenses | 4,415↑2.9% | 4,290↑3.4% | 4,149↑1.1% | 4,105↓5.0% | 4,322 | |
| Operating Results | ||||||
| Operating Income | 1,030↓10.5% | 1,151↑9.5% | 1,051↓4.5% | 1,100↓1.3% | 1,114 | |
| Depreciation & Amortization | 362↑16.8% | 310↑5.1% | 295↑0.0% | 295↓7.8% | 320 | |
| EBITDA | 1,407↓6.8% | 1,510↑26.8% | 1,191↓13.3% | 1,373↓2.5% | 1,409 | |
| EBIT | 1,031↓10.6% | 1,153↑49.2% | 773↓28.3% | 1,078↓1.0% | 1,089 | |
| Interest & Other Income | ||||||
| Net Interest Income | -103↓21.2% | -85↓4.9% | -81↓11.0% | -73↓4.4% | -70 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 103↑21.2% | 85↑4.9% | 81↑11.0% | 73↑4.4% | 70 | |
| Non-Operating Income | -1↑50.0% | -2↓100.7% | 278↑1163.6% | 22↓12.8% | 25 | |
| Other Income / Expenses | -102↓22.9% | -83↑76.9% | -359↓277.9% | -95↑0.2% | -95 | |
| Income Before Tax | 928↓13.1% | 1,068↑54.3% | 692↓31.1% | 1,005↓1.4% | 1,019 | |
| Income Tax Expense | 62↓45.1% | 113↑22.8% | 92↓63.6% | 253↑30.9% | 193 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 880↓12.2% | 1,002↑38.6% | 723↓3.9% | 752↓8.9% | 826 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 880↓12.2% | 1,002↑38.6% | 723↓3.9% | 752↓8.9% | 826 | |
| Bottom-Line Net Income | 880↓12.2% | 1,002↑38.6% | 723↓3.9% | 752↓8.9% | 826 | |
| EPS (Basic) | 3.12↓11.4% | 3.52↑39.7% | 2.52↑5.0% | 2.40↓5.9% | 2.55 | |
| EPS (Diluted) | 3.07↓11.3% | 3.46↑39.0% | 2.49↑4.2% | 2.39↓5.2% | 2.52 | |
| Weighted Average Shares | 282↓1.0% | 285↓0.7% | 287↓8.4% | 313↓3.4% | 324 | |
| Weighted Average Diluted Shares | 286↓1.2% | 290↓0.3% | 291↓7.7% | 315↓3.8% | 327 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.